Drug manufacturer Astellas will let 340B covered entities using “a compliant 340B inventory replenishment model” count accumulations of its antifungal Cresemba under its old National Drug Code toward replenishment of equal quantities under the product’s corresponding new NDC, the company
…
Policymakers should consider disbanding the 340B program “given its negative reverberations for patients and markets,” a student and a professor at the Stanford University School of Medicine wrote in a commentary in the latest edition of the New England Journal
…
The Medicare Payment Advisory Commission, as expected, has voted to recommend that Congress should start phasing in a new way of distributing extra Medicare payments to safety net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.
The proposal that
…
SPONSORED CONTENT
The monkeypox (renamed mpox by the World Health Organization) outbreak took the world by storm in early May of 2022 on the heels of the COVID-19 pandemic. The AIDS Healthcare Foundation (AHF) was among the first public health organizations to sound the
…
Ryan White Clinics for 340B Access is dropping its lawsuit that, together with a related case, led federal health officials to issue long-delayed dispute resolution rules for the 340B program in December 2020.
RWC-340B, five co-plaintiff 340B covered entities, and
…
The Pennsylvania Department of Human Services yesterday rescinded Medicaid policy guidance dated Dec. 22 and effective Jan. 1 that forbade 340B covered entities’ contract pharmacies from dispensing 340B-purchased drugs to Medicaid beneficiaries.
The state primary care association warned that the
…
Oregon legislators have introduced a bill that would prohibit discriminatory practices by pharmacy benefit managers and insurance plans against 340B pharmacies, including reimbursing a 340B pharmacy less for prescription drugs compared with non-340B pharmacies.
If passed later this year, House
…
A federal district court in South Carolina yesterday sealed the federal government’s records of the audit, expulsion, and reinstatement of a health center for allegedly diverting 340B-acquired drugs to ineligible patients.
The court order was in Genesis Health Care’s lawsuit
…
Annual recertification of 340B eligibility for federally qualified health centers and most other grantee-type entities will start Jan. 30 and end Feb. 27, the U.S. Health Resources and Services Administration said yesterday.
HRSA did not say when Title X family
…
SPONSORED CONTENT
Increasingly, participants in Accountable Care Organizations (ACOs) are discovering and benefiting from the 340B drug discount program. Unlike the historic fee-for-service healthcare models, ACOs are rewarded for outcomes that are better aligned with value-based population health, including improved patient care outcomes, an
…
×
*Sign up for news summaries and alerts from 340B Report
